TTHARTharimmune Inc.

Tharimmune Inc.

THAR

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive THAR chart

  • Mkt cap

    $187.37M

  • EV/Sales

    N/A

  • P/E ratio

    N/A

  • Revenue (qtr ended 2026-06-30)

    $1.50M

  • EPS (qtr ended 2026-06-30)

    N/A

  • Gross Margin (qtr ended 2026-06-30)

    N/A

  • Profit Margin (qtr ended 2026-06-30)

    -1287.21%

  • Beta

    N/A

  • Div yield

    N/A

  • Sector

    Healthcare

Live THAR terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

THAR — Tharimmune Inc. · $187.4M cap

THAR Key Statistics

  • Market Cap: $187.4M
  • P/B Ratio: 0.50

Tharimmune Inc. latest statements (FY2025)

Latest cached year on this hub. Full THAR income, balance, and cash tables.

  • Net Income-$35.9M
  • Total Assets$519.1M

THAR recent filings

THAR FAQ

What industry is THAR in?

Tharimmune Inc. (THAR) is a biotechnology company in the Healthcare sector.

What are THAR's latest revenue and net income?

Latest cached Tharimmune Inc. (THAR) revenue for Jun 30, 2026 was $1.5M. Net income was -$19.3M. Statements: https://lician.com/financials/thar

What is THAR's market cap?

Tharimmune Inc. (THAR) market capitalization is $187.4M on the latest cached snapshot.

What is the latest THAR SEC filing?

The latest cached THAR filing is 8-K · Jan 15, 2026. Filings: https://lician.com/sec/thar

Live THAR terminal loads when you scroll near this section.